CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $385,000 | -12.7% | 66,000 | +1.0% | 0.01% | -23.1% |
| Q2 2020 | $441,000 | +58.6% | 65,334 | +49.7% | 0.01% | +18.2% |
| Q1 2020 | $278,000 | -60.8% | 43,633 | -35.8% | 0.01% | -8.3% |
| Q4 2019 | $709,000 | +178.0% | 68,000 | +4.6% | 0.01% | +140.0% |
| Q3 2019 | $255,000 | -75.5% | 65,000 | -7.1% | 0.01% | -82.1% |
| Q2 2019 | $1,041,000 | -23.8% | 70,000 | +27.3% | 0.03% | -17.6% |
| Q1 2019 | $1,366,000 | +280.5% | 55,000 | +175.0% | 0.03% | +126.7% |
| Q4 2018 | $359,000 | -42.5% | 20,000 | -5.8% | 0.02% | -6.2% |
| Q3 2018 | $624,000 | -35.1% | 21,231 | +0.4% | 0.02% | -30.4% |
| Q2 2018 | $961,000 | -5.7% | 21,139 | +9.5% | 0.02% | -28.1% |
| Q1 2018 | $1,019,000 | -40.1% | 19,300 | -22.8% | 0.03% | -27.3% |
| Q4 2017 | $1,700,000 | -31.2% | 25,000 | -16.7% | 0.04% | -52.2% |
| Q3 2017 | $2,472,000 | +55.3% | 30,000 | +76.5% | 0.09% | +37.3% |
| Q2 2017 | $1,592,000 | +13.6% | 17,000 | -22.7% | 0.07% | +19.6% |
| Q1 2017 | $1,401,000 | +277.6% | 22,000 | +340.0% | 0.06% | +250.0% |
| Q1 2015 | $371,000 | -33.8% | 5,000 | -50.0% | 0.02% | -15.8% |
| Q4 2014 | $560,000 | -17.6% | 10,000 | -33.3% | 0.02% | +11.8% |
| Q3 2014 | $680,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |